SGMT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SGMT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Sagimet Biosciences's average diluted shares outstanding for the quarter that ended in Sep. 2024 was 32.14 Mil.
The historical data trend for Sagimet Biosciences's Shares Outstanding (Diluted Average) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sagimet Biosciences Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Shares Outstanding (Diluted Average) | 22.17 | 22.17 | 22.17 | 22.17 | 10.46 |
Sagimet Biosciences Quarterly Data | ||||||||||||||||
Dec19 | Mar20 | Dec20 | Mar21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Shares Outstanding (Diluted Average) | Get a 7-Day Free Trial | 18.20 | 22.90 | 29.04 | 31.91 | 32.14 |
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.
Sagimet Biosciences (NAS:SGMT) Shares Outstanding (Diluted Average) Explanation
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Be Aware
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Thank you for viewing the detailed overview of Sagimet Biosciences's Shares Outstanding (Diluted Average) provided by GuruFocus.com. Please click on the following links to see related term pages.
George Kemble | director | SAGIMET BIOSCIENCES INC., 155 BOVET RD., STE. 303, SAN MATEO CA 94402 |
Elizabeth Rozek | officer: General Counsel and CCO | SAGIMET BIOSCIENCES INC., 155 BOVET ROAD, SUITE 303, SAN MATEO CA 94402 |
Eduardo Bruno Martins | director | 350 CAMBRIDGE AVE, SUITE 350, PALO ALTO CA 94306 |
David Happel | director, officer: President & CEO | 7 HAMILTON LANDING, SUITE 100, NOVATO CA 94949 |
New Enterprise Associates 13 Lp | 10 percent owner | 1119 ST PAUL STREET, BALTIMORE MD 21202 |
Beth C Seidenberg | director | |
Nea 13 Gp, Ltd | 10 percent owner | 1119 ST. PAUL STREET, BALTIMORE MD 21202 |
Jinzi Jason Wu | director | SAGIMET BIOSCIENCES INC., 155 BOVET RD., SUITE 303, SAN MATEO CA 94402 |
Dennis Hom | officer: Chief Financial Officer | C/O ACHAOGEN, INC., 7000 SHORELINE COURT, SUITE 371, SOUTH SAN FRANCISCO CA 94080 |
Kpcb Pbd Associates, Llc | 10 percent owner | C/O KLEINER PERKINS CAUFIELD & BYERS, 2750 SAND HILL ROAD, MENLO PARK CA 94025 |
Kpcb Pandemic & Bio Defense Fund Llc | 10 percent owner | 2750 SAND HILL RD, MENLO PARK CA 94025 |
Nea Partners 13, Limited Partnership | 10 percent owner | 1119 ST. PAUL STREET, BALTIMORE MD 21202 |
Elizabeth A Grammer | director | 78TH FOURTH AVENUE, WALTHAM MA 02451 |
Anthony M Rimac | officer: Chief Operating Officer | C/O ADAMAS PHARMACEUTICALS, INC., 2200 POWELL ST, STE 220, EMERYVILLE CA 94608 |
Patrick J Kerins | 10 percent owner |
From GuruFocus
By Marketwired • 10-16-2024
By Marketwired • 08-21-2023
By Marketwired • 10-29-2024
By GuruFocus News • 11-15-2024
By Marketwired • 05-15-2024
By Marketwired • 09-04-2024
By Marketwired • 10-01-2024
By Marketwired • 10-18-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.